Author:
Shi Tiange,Browne Richard W.,Tamaño-Blanco Miriam,Jakimovski Dejan,Weinstock-Guttman Bianca,Zivadinov Robert,Ramanathan Murali,Blair Rachael H.
Funder
Congressionally Directed Medical Research Programs
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference49 articles.
1. Aasly, J., Gårseth, M., Sonnewald, U., Zwart, J. A., White, L., & Unsgård, G. (1997). Cerebrospinal fluid lactate and glutamine are reduced in multiple sclerosis. Acta Neurologica Scandinavica, 95(1), 9–12. https://doi.org/10.1111/j.1600-0404.1997.tb00060.x?sid=nlm/3Apubmed
2. Bates, D., Sarkar, D., Bates, M. D., & Matrix, L. (2007). The lme4 package. R Package Version, 2(1), 74.
3. Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (methodological), 57(1), 289–300.
4. Cicalini, I., Rossi, C., Pieragostino, D., Agnifili, L., Mastropasqua, L., di Ioia, M., De Luca, G., Onofrj, M., Federici, L., & Del Boccio, P. (2019). Integrated lipidomics and metabolomics analysis of tears in multiple sclerosis: An insight into diagnostic potential of lacrimal fluid. International Journal of Molecular Sciences, 20(6), 1265.
5. Confavreux, C., & Vukusic, S. (2006). Natural history of multiple sclerosis: A unifying concept. Brain, 129(3), 606–616.